He was a postdoctoral scientist at Applied Molecular Evolution, where he produced and screened random
peptide phage display libraries with soluble empty mouse CD1 (mCD1) to identify a peptide - binding motif for MHC Class I like receptors.
Utilizing multiple discovery platforms including; forward genetic screens (shRNA),
phage - based
peptide display, and ChIP - Seq to identify novel molecular interactions that occur during the development of IBC and metastatic breast cancer